Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

PhotonPharma Inc. Receives U.S. Patent for Innovative Cancer Immunotherapy

Summary by CNHI News
Patent Covers Novel Method for Producing Photosensitizer-Inactivated Cancer Cell with Enhanced Immunogenicity for use in Cancer Immunotherapy

20 Articles

Albuquerque JournalAlbuquerque Journal
+19 Reposted by 19 other sources
Center

PhotonPharma Inc. Receives U.S. Patent for Innovative Cancer Immunotherapy

Patent Covers Novel Method for Producing Photosensitizer-Inactivated Cancer Cell with Enhanced Immunogenicity for use in Cancer Immunotherapy

·Albuquerque, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 89% of the sources are Center
89% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Monday, September 8, 2025.
Sources are mostly out of (0)

Similar News Topics

United States icon

United States

News
For You
SearchBlindspotLocal